'Miracle' Cystic Fibrosis Drug Kept Out of Reach in Developing Countries

Vertex Pharmaceuticals is not making its drug, Trikafta, available in poorer countries, where thousands of diagnosed patients stand to benefit.

Related Keywords

New York ,United States ,Latvia ,Milan ,Lombardia ,Italy ,Istanbul ,Turkey ,United Kingdom ,Argentina ,Brazil ,Boston ,Massachusetts ,South Africa ,Woman ,Ukraine ,Hyderabad ,Andhra Pradesh ,India ,Estonia ,Mumbai ,Maharashtra ,Slovenia ,Curitiba ,Paranár ,Bulgaria ,Prague ,Praha ,Hlavníesto ,Czech Republic ,Poland ,Romania ,Greece ,Britain ,America ,Brazilian ,Turkish ,Argentine ,Dado Galdieri ,Heather Nichols ,Bulent Karadag ,Raphaelle Pereira ,Seshagiri Buddana ,Belinda Nell ,Cheri Nel ,Hemanth Buddana ,Gautam Adani ,Macek Jr ,Shwetha Sree ,Google ,Vertex Pharmaceuticals ,New York Times ,Adani Group ,Latin America ,Big Screen ,Cram City ,Northern European ,Saharan Africa ,Medicines Patent Pool ,United Nations Backed ,Middle East ,Eastern Europe ,Central Asia ,Cystic Fibrosis ,Pharmaceuticals Prescription Drugs ,Third World ,Inventions And Patents ,Generic Brand ,